FDA.reportPublic FDA data

{90 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 12]

RxCUI
2054159
RxNorm name
{90 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 12]
Display name
{90 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 12]
Full name
{90 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 12]
Term type
BPCK
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f4bedd21-efde-44c6-9d9c-b48b78d7ed1e{90 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 12] [BPCK] · Lenvima 12 MG daily dose 30 Day Supply Pack [PSN] · Lenvima 12 MG (as lenvatinib mesylate) Daily Dose 30 Day Supply Pack [SY]378These highlights do not include all the information needed to use LENVIMA safely and effectively. See full prescribing information for LENVIMA . LENVIMA ® ( lenvatinib ) capsules , for oral use Initial U.S. Approval: 201520250103